What is she best known for?
The fields of study she is best known for:
- Cancer
- Gene
- Internal medicine
Beth Y. Karlan mostly deals with Ovarian cancer, Internal medicine, Cancer research, Cancer and Oncology.
Ovarian cancer is a subfield of Genetics that she studies.
Her Internal medicine research includes themes of Gastroenterology and Endocrinology.
Her studies in Cancer research integrate themes in fields like Mutation, Germline mutation, DNA methylation, microRNA and Tumor suppressor gene.
Beth Y. Karlan has researched DNA methylation in several fields, including Ovarian carcinoma and Methylation.
As part of one scientific family, Beth Y. Karlan deals mainly with the area of Oncology, narrowing it down to issues related to the Colorectal cancer, and often Genetic testing.
Her most cited work include:
- Integrated genomic analyses of ovarian carcinoma (5056 citations)
- Integrated genomic analyses of ovarian carcinoma (5056 citations)
- Integrated genomic characterization of endometrial carcinoma (2600 citations)
What are the main themes of her work throughout her whole career to date?
Her primary scientific interests are in Ovarian cancer, Internal medicine, Oncology, Cancer research and Cancer.
Her research on Ovarian cancer focuses in particular on Ovarian carcinoma.
Her Internal medicine study frequently links to adjacent areas such as Endocrinology.
In her study, which falls under the umbrella issue of Oncology, Case-control study is strongly linked to Odds ratio.
Her Cancer research research includes elements of DNA methylation, Cancer cell, Carcinogenesis, Gene and Metastasis.
Her Gynecology research incorporates elements of Family history and Obstetrics.
She most often published in these fields:
- Ovarian cancer (51.17%)
- Internal medicine (46.95%)
- Oncology (36.78%)
What were the highlights of her more recent work (between 2019-2021)?
- Internal medicine (46.95%)
- Oncology (36.78%)
- Ovarian cancer (51.17%)
In recent papers she was focusing on the following fields of study:
Beth Y. Karlan mainly investigates Internal medicine, Oncology, Ovarian cancer, Breast cancer and Cancer.
Her study looks at the relationship between Internal medicine and fields such as Genetic correlation, as well as how they intersect with chemical problems.
Her work deals with themes such as Precision medicine, Epidemiology, Serous fluid, Single-nucleotide polymorphism and Endometrial cancer, which intersect with Oncology.
Her Serous fluid research integrates issues from Ovarian carcinoma, Transcriptome, Ovarian tumor, Biomarker and Histology.
Her studies deal with areas such as Cancer research, Genome-wide association study, Disease and Germline as well as Ovarian cancer.
The Breast cancer study combines topics in areas such as Published Erratum, Mutation and Bioinformatics.
Between 2019 and 2021, her most popular works were:
- Pan-cancer analysis of whole genomes (751 citations)
- Genetic/familial high-risk assessment: Breast, ovarian, and pancreatic, version 2.2021 (123 citations)
- Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses (53 citations)
In her most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
Beth Y. Karlan mainly focuses on Oncology, Internal medicine, Ovarian cancer, Serous fluid and Cancer.
Beth Y. Karlan interconnects Genome-wide association study, Germline, Hazard ratio, Stage and Breast cancer in the investigation of issues within Oncology.
The study of Internal medicine is intertwined with the study of Cancer syndrome in a number of ways.
Beth Y. Karlan has included themes like Epidemiology, Cell type, Disease and Mesenchymal stem cell, Cell biology in her Ovarian cancer study.
The study incorporates disciplines such as PAX8, Ovarian carcinoma, Transcriptome, Fallopian tube and Ovarian tumor in addition to Serous fluid.
Her Cancer study combines topics in areas such as Oophorectomy and Adverse effect.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
